Physicians at the University of Illinois Hospital & Health Sciences System have cured 12 adult patients of sickle cell disease using a unique procedure for stem cell transplantation from healthy, tissue-matched siblings.
The transplants were the first to be performed outside of the National Institutes of Health campus in Maryland, where the procedure was developed. Physicians there have treated 30 patients, with an 87 percent success rate. The results of the phase I/II clinical trial at UI Health, in which 92 percent of treated patients were cured, are published online in the journal Biology of Blood & Marrow Transplantation.
The new technique eliminates the need for chemotherapy to prepare the patient to receive the transplanted cells and offers the prospect of cure for tens of thousands of adults suffering from sickle cell disease.
About 90 percent of the approximately 450 patients who have received stem cell transplants for sickle cell disease have been children. Chemotherapy has been considered too risky for adult patients, who are often more weakened than children by the disease.
“Adults with sickle cell disease are now living on average until about age 50 with blood transfusions and drugs to help with pain crises, but their quality of life can be very low,” says Dr. Damiano Rondelli, chief of hematology/oncology and director of the blood and marrow transplant program at UI Health, and corresponding author on the paper.
“Now, with this chemotherapy-free transplant, we are curing adults with sickle cell disease, and we see that their quality of life improves vastly within just one month of the transplant,” said Rondelli, who is also the Michael Reese Professor of Hematology in the UIC College of Medicine. “They are able to go back to school, go back to work, and can experience life without pain.”
Sickle cell disease is inherited. It primarily affects people of African descent, including about one in every 500 African Americans born in the U.S. The defect causes the oxygen-carrying red blood cells to be crescent shaped, like a sickle. The misshapen cells deliver less oxygen to the body’s tissues, causing severe pain and eventually stroke or organ damage.
Doctors have known for some time that bone marrow transplantation from a healthy donor can cure sickle cell disease. But few adults were transplanted because high-dose chemotherapy was needed to kill off the patients’ own blood-forming cells — and their entire immune system, to prevent rejection of the transplanted cells, leaving patients open to infection.
In the new procedure, patients receive immunosuppressive drugs just before the transplant, along with a very low dose of total body irradiation — a treatment much less harsh and with fewer potentially serious side effects than chemotherapy.
Next, donor cells from a healthy and tissue-matched sibling are transfused into the patient. Stem cells from the donor produce healthy new blood cells in the patient, eventually in sufficient quantity to eliminate symptoms. In many cases, sickle cells can no longer be detected. Patients must continue to take immunosuppressant drugs for at least a year.
In the reported trial, the researchers transplanted 13 patients, 17 to 40 years of age, with a stem cell preparation from the blood of a tissue-matched sibling. Healthy sibling donor-candidates and patients were tested for human leukocyte antigen, a set of markers found on cells in the body. Ten of these HLA markers must match between the donor and the recipient for the transplant to have the best chance of evading rejection.
In a further advance of the NIH procedure, physicians at UI Health successfully transplanted two patients with cells from siblings who matched for HLA but had a different blood type.
In all 13 patients, the transplanted cells successfully took up residence in the marrow and produced healthy red blood cells. One patient who failed to follow the post-transplant therapy regimen reverted to the original sickle cell condition.
None of the patients experienced graft-versus-host disease, a condition where immune cells originating from the donor attack the recipient’s body.
One year after transplantation, the 12 successfully transplanted patients had normal hemoglobin concentrations in their blood and better cardiopulmonary function. They reported less pain and improved health and vitality.
Four of the patients were able to stop post-transplantation immunotherapy without transplant rejection or other complications.
The Latest on: Sickle cell disease
via Google News
The Latest on: Sickle cell disease
- Sickle cell and barriers to black blood donorson October 18, 2019 at 4:05 pm
Not too long ago, I was listening to the BBC London news, when it did a segment on sickle cell disease and the lack of black blood donors. The report was an interesting one, highlighting the story of ...
- PT deaths spurred Air Force to screen for sickle cell trait ahead of fitness assessmentson October 17, 2019 at 11:09 pm
Most people with sickle cell trait never develop any of the symptoms of sickle cell disease, which is a serious medical condition, according to the Centers for Disease Control and Prevention. However, ...
- Sickle Cell Disease: Challenges From the Payer Perspectiveon October 16, 2019 at 1:21 pm
The panelists consider remaining challenges in sickle cell disease as they relate to the payer’s role. Neil B. Minkoff, MD: We’ve talked a fair amount about the different challenges to the patient in ...
- Steelers Super Bowl MVP Hosts Bowling Fundraiser For Sickle Cell Researchon October 15, 2019 at 8:33 pm
Santonio Holmes hosted the “Strikes Against Sickle Cell” fundraiser at Noble Manor Lanes on Tuesday. The event raises money for research and education of sickle cell disease. Holmes’ son inherited the ...
- Scientists have treated a patient with sickle cell disease by editing their DNAon October 14, 2019 at 5:00 am
A sickle disease patient could be given a new lease of life after scientists modified her DNA in an experimental procedure. Victoria Gray, 34, has suffered from the red blood cell defect from a young ...
- Suffolk teen spreading hope for others with sickle cell diseaseon October 14, 2019 at 4:47 am
SUFFOLK, Va. (WAVY) – A 13-year-old Suffolk resident is on a mission to raise awareness about sickle cell disease. Ayana Johnson has been in and out of hospitals since she was diagnosed with the ...
- New Screening Method Benefits Families With Pediatric Sickle Cell Diseaseon October 12, 2019 at 10:30 pm
Hematologists can uncover the needs of families with sickle cell disease affected children and connect them to local resources within a clinic visit with the hope of improving quality of life and ...
- Social determinant screening useful for families with pediatric sickle cell diseaseon October 10, 2019 at 7:50 am
Individuals with sickle cell disease (SCD) face the burdens of chronic illness and often racial disparities, both of which may increase vulnerability to adverse social determinants of health (SDoH).
- After A Life Of Painful Sickle Cell Disease, A Patient Hopes Gene-Editing Can Helpon October 10, 2019 at 2:24 am
Victoria Gray slides open a closet door, pulls out a suitcase and starts packing piles of clothes. "My goodness," says Gray. "Did I really bring all this?" Gray, who has sickle cell disease, is the ...
- Management of sickle cell diseaseon October 9, 2019 at 7:54 pm
The Anambra State House of Assembly recently outlawed marriages involving people living with sickle cell anaemia. The bill, cited as Sickle Cell Disease Control and Eradication Repeal, sought to ...
via Bing News